← Leaderboards
Carlos Dedesma
Vizma Life Sciences, Inc.
$580,266
Attributed
$1,252,078
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $713.2K · FY2022–23$1M$750K$500K$250K$0
'22
'23
Funding mix
By agency
NIH$1,252,078 · 2
By mechanism
R43$1,252,078 · 2
Top collaborators
- Patrick Tomhon4 shared
- Thomas Theis1 shared
Most similar at Vizma Life Sciences, Inc.
Same institution · by research overlap
- Patrick Tomhon$580,266
Others in their field
Other Rising Stars on “Pre-Clinical”
- Nancy Jean Sullivan · Boston University Medical Campus$34,500,000
- Taleen Hanania · Psychogenics, Inc.$21,254,211
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$13,657,841
- Chris Maxwell · National Institute Of Allergy And Infectious Diseases$12,000,000
Research focus
Pre-ClinicalSymptomsMetabolismPositron-Emission TomographySignal TransductionSmall Business Innovation Research GrantImaging DeviceMetabolic ImagingMolecularPathway InteractionsInsightReportingSingle Photon Emission Computed TomographyEarly DiagnosisImageFunctional DisorderInfrastructureMagnetic Resonance ImagingCostImaging ModalityMolecular ImagingNon-Invasive ImagingInjectableTechnology
Grant awards (4)
Automated microfluidic hyperpolarization reactor for neurometabolic imaging$438,569
R43 · FY2023 · MH
Non-invasive molecular imaging tool for rapid, longitudinal assessment of localized metabolic disruptions in animal research and care$274,637
R43 · FY2023 · OD
Automated microfluidic hyperpolarization reactor for neurometabolic imaging$447,959
R43 · FY2022 · MH
Automated microfluidic hyperpolarization reactor for neurometabolic imaging$90,913
R43 · FY2022 · MH